Allurion Technologies (NYSE:ALUR) Now Covered by Jefferies Financial Group

Analysts at Jefferies Financial Group initiated coverage on shares of Allurion Technologies (NYSE:ALURGet Free Report) in a report issued on Friday, Briefing.com reports. The firm set a “buy” rating and a $5.00 price target on the stock. Jefferies Financial Group’s price objective points to a potential upside of 68.92% from the stock’s previous close.

Allurion Technologies Trading Down 1.0 %

Shares of ALUR opened at $2.96 on Friday. Allurion Technologies has a 52-week low of $2.63 and a 52-week high of $9.00. The firm has a 50 day simple moving average of $3.35.

Allurion Technologies (NYSE:ALURGet Free Report) last issued its quarterly earnings results on Monday, November 13th. The company reported ($0.61) earnings per share (EPS) for the quarter. The business had revenue of $18.20 million during the quarter.

Institutional Investors Weigh In On Allurion Technologies

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. purchased a new stake in shares of Allurion Technologies during the 3rd quarter valued at $1,932,000. RTW Investments LP bought a new position in shares of Allurion Technologies during the 3rd quarter worth $14,868,000. Alpine Global Management LLC bought a new position in shares of Allurion Technologies during the 3rd quarter worth $97,000. Northern Trust Corp bought a new position in shares of Allurion Technologies during the 3rd quarter worth $267,000. Finally, Accredited Investors Inc. bought a new position in shares of Allurion Technologies during the 3rd quarter worth $161,000. 26.55% of the stock is owned by hedge funds and other institutional investors.

About Allurion Technologies

(Get Free Report)

Allurion Technologies Inc focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.

Featured Stories

Receive News & Ratings for Allurion Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allurion Technologies and related companies with MarketBeat.com's FREE daily email newsletter.